Regulatory press release8/1/2024, 6:45 AMThe subscription period in Cyxone's rights issue starts today
Regulatory press release7/23/2024, 6:30 AMCyxone: Styrelsen beslutar om företrädesemission om högst cirka 23 MSEK för att finansiera fortsatt utveckling av rabeximod och T20K
Regulatory press release7/23/2024, 6:30 AMCyxone: The board decides on a rights issue of a maximum of approximately SEK 23 million to finance continued development of rabeximod and T20K